HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Matthew J Niederst Selected Research

Matthew J Niederst Research Topics

Disease

16Neoplasms (Cancer)
01/2024 - 01/2013
11Lung Neoplasms (Lung Cancer)
01/2024 - 09/2013
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2023 - 02/2014
1Colorectal Neoplasms (Colorectal Cancer)
01/2023
1Disease Progression
04/2016
1Adenocarcinoma
09/2015
1Prostatic Neoplasms (Prostate Cancer)
01/2013

Drug/Important Bio-Agent (IBA)

7ErbB Receptors (EGF Receptor)IBA
01/2019 - 09/2013
4Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2023 - 09/2013
3Phosphotransferases (Kinase)IBA
10/2017 - 09/2013
2Drug CombinationsIBA
11/2023 - 12/2014
2nazartinibIBA
01/2018 - 03/2016
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2017 - 09/2013
2rociletinibIBA
04/2016 - 07/2015
2Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2016 - 09/2015
2Tyrosine Kinase InhibitorsIBA
03/2015 - 12/2014
2Anaplastic Lymphoma KinaseIBA
12/2014 - 09/2013
1Transcription Factors (Transcription Factor)IBA
01/2024
1Adenosine Triphosphatases (ATPase)IBA
01/2024
1Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA
01/2019
1navitoclaxIBA
01/2018
1Complement System Proteins (Complement)IBA
12/2017
1DNA (Deoxyribonucleic Acid)IBA
12/2017
1RNA (Ribonucleic Acid)IBA
12/2017
1Mitogen-Activated Protein KinasesIBA
01/2017
1osimertinibIBA
04/2016
1CrizotinibIBA
01/2016
1Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
12/2014
1Phosphatidylinositols (Phosphatidylinositol)IBA
02/2014
1SaltsIBA
02/2014
1tyrosine receptor (receptor, tyrosine)IBA
09/2013
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
09/2013
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
09/2013
1TensinsIBA
01/2013
1PTEN Phosphohydrolase (PTEN Phosphatase)IBA
01/2013
1IsoenzymesIBA
01/2013

Therapy/Procedure

9Therapeutics
01/2023 - 12/2014
2Drug Therapy (Chemotherapy)
11/2023 - 03/2016
1Aftercare (After-Treatment)
01/2018